These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29740794)

  • 21. [Idiopathic nephrotic syndrome: une Arlésienne?].
    Lorenzo HK; Candelier JJ
    Med Sci (Paris); 2019; 35(8-9):659-666. PubMed ID: 31532378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal segmental glomerulosclerosis complicating solitary kidney.
    Oshiro Y; Umena S; Noda M
    Clin Exp Nephrol; 2009 Feb; 13(1):81-4. PubMed ID: 18688570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
    Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
    BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathogenesis of focal segmental glomerulosclerosis.
    Jefferson JA; Shankland SJ
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):408-16. PubMed ID: 25168829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First identification of
    Lin FJ; Yao L; Hu XQ; Bian F; Ji G; Jiang GR; Gale DP; Ren HQ
    Clin Sci (Lond); 2019 Jan; 133(1):9-21. PubMed ID: 30523047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS).
    Shiiki H; Nishino T; Uyama H; Kimura T; Nishimoto K; Iwano M; Kanauchi M; Fujii Y; Dohi K
    Clin Nephrol; 1996 Dec; 46(6):362-8. PubMed ID: 8982551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary podocytes in primary focal segmental glomerulosclerosis.
    Hara M; Yanagihara T; Kihara I
    Nephron; 2001 Nov; 89(3):342-7. PubMed ID: 11598401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transplantation nephrotic syndrome.
    Stokes MB; De Palma J
    Kidney Int; 2006 Mar; 69(6):1088-91. PubMed ID: 16482097
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis.
    Aparecida da Silva C; Molinar Mauad Cintra M; de Castro Côbo E; Vinícius da Silva M; Bichuette Custódio F; Rosa Miranda Corrêa R; Roberto Castellano L; Antônia dos Reis M; Reis Machado J
    Dis Markers; 2014; 2014():192836. PubMed ID: 24719498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis.
    Sharif B; Barua M
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):194-200. PubMed ID: 29465426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
    Shoji J; Mii A; Terasaki M; Shimizu A
    Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
    McAdams AJ; Valentini RP; Welch TR
    Medicine (Baltimore); 1997 Jan; 76(1):42-52. PubMed ID: 9064487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
    Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Minimal change disease and focal segmental glomerulosclerosis].
    Müller-Deile J; Schenk H; Schiffer M
    Internist (Berl); 2019 May; 60(5):450-457. PubMed ID: 30887070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS;
    Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Available and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults.
    Belingheri M; Moroni G; Messa P
    J Nephrol; 2018 Feb; 31(1):37-45. PubMed ID: 28470475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations of type IV collagen-encoding genes in patients with histological diagnosis of focal segmental glomerulosclerosis.
    Demir E; Caliskan Y
    Pediatr Nephrol; 2020 Jun; 35(6):927-936. PubMed ID: 31254113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal segmental glomerulosclerosis with and without nephrotic syndrome in children.
    Yoshikawa N; Ito H; Akamatsu R; Matsuyama S; Hasegawa O; Nakahara C; Matsuo T
    J Pediatr; 1986 Jul; 109(1):65-70. PubMed ID: 3723242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.